PL1680430T3 - Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu - Google Patents

Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu

Info

Publication number
PL1680430T3
PL1680430T3 PL04820865T PL04820865T PL1680430T3 PL 1680430 T3 PL1680430 T3 PL 1680430T3 PL 04820865 T PL04820865 T PL 04820865T PL 04820865 T PL04820865 T PL 04820865T PL 1680430 T3 PL1680430 T3 PL 1680430T3
Authority
PL
Poland
Prior art keywords
processes
clopidogrel bisulfate
preparing form
preparation
clopidogrel
Prior art date
Application number
PL04820865T
Other languages
English (en)
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Bipin Pandey
Mayankghanshyambhai Dave
Parind Narendra Dholakia
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of PL1680430T3 publication Critical patent/PL1680430T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
PL04820865T 2003-11-03 2004-11-02 Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu PL1680430T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1154MU2003 2003-11-03
IN1217MU2003 2003-11-25
EP04820865A EP1680430B1 (en) 2003-11-03 2004-11-02 Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
PCT/IN2004/000341 WO2005063708A2 (en) 2003-11-03 2004-11-02 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate

Publications (1)

Publication Number Publication Date
PL1680430T3 true PL1680430T3 (pl) 2010-06-30

Family

ID=34740781

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04820865T PL1680430T3 (pl) 2003-11-03 2004-11-02 Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu

Country Status (12)

Country Link
US (2) US8907090B2 (pl)
EP (2) EP1680430B1 (pl)
KR (2) KR101110738B1 (pl)
AT (1) ATE455778T1 (pl)
CA (2) CA2676121A1 (pl)
DE (1) DE602004025267D1 (pl)
DK (1) DK1680430T3 (pl)
ES (1) ES2339944T3 (pl)
NO (1) NO20062062L (pl)
PL (1) PL1680430T3 (pl)
PT (1) PT1680430E (pl)
WO (1) WO2005063708A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003238664A1 (en) * 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP1618111B1 (en) * 2003-04-25 2014-12-24 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
PL1680430T3 (pl) 2003-11-03 2010-06-30 Cadila Healthcare Ltd Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu
WO2006074066A1 (en) * 2004-12-30 2006-07-13 Nektar Therapeutics Non-crystalline formulation comprising clopidogrel
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
KR101378596B1 (ko) * 2006-12-27 2014-03-26 경동제약 주식회사 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
EP2300480A2 (en) * 2008-06-24 2011-03-30 ZaCh System S.p.A. Process for the preparation of clopidogrel hydrogen sulfate crystalline form i
KR101616928B1 (ko) * 2010-01-07 2016-05-02 동화약품주식회사 클로피도그렐 황산수소염 결정형（ｉ）의 제조방법
CN102558194A (zh) * 2010-12-11 2012-07-11 山东方明药业股份有限公司 一种硫酸氢氯吡格雷i型的制备方法
KR101567438B1 (ko) 2013-11-15 2015-11-12 대구가톨릭대학교산학협력단 클로피도그렐 황산염 결정형 ⅰ형의 제조방법
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664276B1 (fr) 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
US5139170A (en) 1990-09-06 1992-08-18 Ad-Tech Plastic Systems Corp. Dispensing apparatus for multiple fluids
FR2760456B1 (fr) 1997-03-05 2000-05-12 Sanofi Sa Procede de preparation de derives de 2-thienyl-ethylamine
HU225503B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
HU225504B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU222283B1 (hu) 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
FR2769313B1 (fr) 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
EP1353928B1 (en) 2001-01-24 2006-12-27 Cadila Healthcare Ltd. Process for preparing clopidogrel
IN191030B (pl) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
CA2470479A1 (en) 2001-12-18 2003-06-26 Teva Pharmaceutical Industries Ltd. Polymorphs of clopidogrel hydrogensulfate
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP1618111B1 (en) 2003-04-25 2014-12-24 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
BR0318449A (pt) * 2003-08-04 2006-08-01 Wockhardt Ltd processo para fabricação de (+)-(s)-clopidogrel bissulfato forma-i
PL1680430T3 (pl) 2003-11-03 2010-06-30 Cadila Healthcare Ltd Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu
AU2004318214B2 (en) 2004-04-09 2007-12-06 Hanmi Holdings Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
KR20070052780A (ko) 2004-09-21 2007-05-22 테바 파마슈티컬 인더스트리즈 리미티드 결정질 클로피도그렐 브롬산염 및 이의 제조 방법
US7446200B2 (en) 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
US20080188663A1 (en) 2007-01-29 2008-08-07 Ashok Kumar Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I

Also Published As

Publication number Publication date
NO20062062L (no) 2006-07-24
CA2676121A1 (en) 2005-07-14
ES2339944T3 (es) 2010-05-27
ATE455778T1 (de) 2010-02-15
DK1680430T3 (da) 2010-05-25
CA2544443A1 (en) 2005-07-14
EP1680430B1 (en) 2010-01-20
PT1680430E (pt) 2010-04-26
KR101050105B1 (ko) 2011-07-19
US20100204268A1 (en) 2010-08-12
KR20070006679A (ko) 2007-01-11
KR101110738B1 (ko) 2012-02-17
CA2544443C (en) 2010-08-17
WO2005063708A2 (en) 2005-07-14
US8907090B2 (en) 2014-12-09
KR20110010809A (ko) 2011-02-07
DE602004025267D1 (de) 2010-03-11
EP2103617A1 (en) 2009-09-23
EP1680430A2 (en) 2006-07-19
WO2005063708A3 (en) 2005-10-06
US20070082924A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
NO2010020I2 (pl)
IL174951A0 (en) Method for the production of amino crotonyl compounds
GB0512560D0 (en) Bioreactors for well treatment
PT1592793E (pt) Compostos oligoméricos para a modulação da expressão de survivina
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
PL371464A1 (pl) 3-Alkilowane 5,5',6,6',7,7',8,8'-oktahydro-2,2'-binaftole i 3,3'-dialkilowane 5,5',6,6',7,7',8,8'-oktahydro-2,2'-binaftole oraz sposoby ich wytwarzania
HUP0401296A3 (en) Novel processes for producing pyrimidinon derivatives
WO2005063708A3 (en) Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
PT1509517E (pt) Nova síntese de irbesartan
IL176328A (en) Method for cleaning fsh
ZA200402472B (en) Method for preparing benzenesulfonyl compounds.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
EP1688422A4 (en) PROCESS FOR PREPARING AN ORGANOSILANE
AU2003294691A8 (en) Method for producing leather
SG144914A1 (en) A method for the preparation of enantiomerically pure mirtazapine
AUPR437601A0 (en) Process for sulphide concentration
EP1436279A4 (en) CHEMICAL COMPOUNDS
GB0119815D0 (en) Method for making masterbatch
IL176153A0 (en) Method for the production of 2,3-cis-substituted 2-aryl propenals
PL371913A1 (pl) Sposoby syntezy beta-L-5-fluoro-2',3'-dideoksy-2',3'-didehydrocytydyny (beta-L-FD4C)
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
TWI319707B (en) Method of purifying pravastatin
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
SI1594879T1 (sl) Postopek in intermediati za pripravo olanzapina
GB2413798B (en) Bioreactors for well treatment